EASD: Alirocumab lipid-lowering benefits extend to patients with high-risk diabetesOctober 1, 2015DiabetesLipid Disorders
EASD: Liraglutide lowers HbA1c when added to insulin in longstanding type 2 diabetesSeptember 30, 2015Diabetes
Evidence links common endocrine-disrupting chemicals to obesity, diabetes, reproductive disordersSeptember 28, 2015DiabetesObesity
Long-acting insulin degludec – and degludec combo drug – win FDA nodSeptember 26, 2015Lipid DisordersDiabetes
EASD: SGLT2 inhibitor empagliflozin cuts CV risk in patients with type 2 diabetesSeptember 18, 2015DiabetesLipid Disorders
